BloFin Leads TOKEN2049 with Most Talked-About Exceptional Branding: Towering Whale Chess, Crane Booth & Full-House Whalefield Afterparty GlobeNewswire October 22, 2025 ROAD TOWN, Virgin Islands, Oct. 22, 2025 (GLOBE NEWSWIRE) — BloFin, a global crypto exchange, took center stage at TOKEN2049 Singapore as Title Sponsor, delivering the most talked-about and exceptional branding experience in the […]

(NYSE:BAM),(TSX:BAM),(NYSE:BAM), NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Brookfield has announced the launch of the Brookfield Private Equity Fund (Canada) (“BPE-CAD” or the “Fund”). The evergreen strategy provides investors streamlined access to Brookfield's leading private equity platform through a simplified investment process that includes monthly subscriptions and a low investment minimum. BPE-CAD builds on

Brookfield Launches New Private Equity Evergreen Fund Structure in Canada GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Brookfield has announced the launch of the Brookfield Private Equity Fund (Canada) (“BPE-CAD” or the “Fund”). The evergreen strategy provides investors streamlined access to Brookfield's leading private equity platform through a simplified investment

(NASDAQ:WGRX), Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) US Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains BEAVERTON, OR, Oct. 22, 2025 (GLOBE NEWSWIRE) — DataVault AI, Inc. (“DataVault”) (NASDAQ: DVLT) , leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ: WGRX),

(NASDAQ:MBCN), MIDDLEFIELD, Ohio, Oct. 22, 2025 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today reported financial results for the nine months ended September 30, 2025. 2025 Third-Quarter Financial Highlights (on a year-over-year basis): â— Third quarter diluted earnings increased to $0.65 per share, driving year-to-date earnings of $2.01 per share â— Pre-tax, pre-provision earnings(1)

IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, production, and commercialization of novel cell therapies, today announced that the Blood published the latest results of its independently developed fully human anti-GPRC5D CAR-T cell therapy, RD118, for the treatment of relapsed/refractory multiple myeloma (R/R MM). The study demonstrates that RD118 exhibited significant

Trading resumes in: Company: West High Yield (W.H.Y.) Resources Ltd. TSX-Venture Symbol: WHY All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national

DataVault AI and Wellgistics Health Announce Plans for PharmacyChain(TM) to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes GlobeNewswire October 22, 2025 Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) US Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains BEAVERTON, OR, Oct.

Middlefield Banc Corp. Reports 2025 Nine-Month Financial Results GlobeNewswire October 22, 2025 MIDDLEFIELD, Ohio, Oct. 22, 2025 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today reported financial results for the nine months ended September 30, 2025. 2025 Third-Quarter Financial Highlights (on a year-over-year basis): â— Third quarter diluted earnings increased to $0.65 per share,

(NYSE:JHX), NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into James Hardie Industries plc (NYSE: JHX) for potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit. Why Is James